If you are:
FDB Contraindicated or Not Recommended: FDA CATEGORY C;SALICYLATES NOT RECOMMENDED ESPECIALLY IN 3RD TRIMESTER/NEAR TERM
Only When Necessary: REPORTS OF MISCARRIAGE,POOR FETAL GROWTH POSSIBLY ASSOC W/HIGH DOSES OF CAFFEINE
Precaution: HIGH DOSES MAY CAUSE HYPERACTIVITY AND WAKEFULNESS IN INFANT.
Absolute Contraindication: ONE REPORT OF METABOL ACIDOSIS W/ASA;RISK OF REYE'S SYN W/VIRAL ILLNESS/FEVER
No Known Risk: LOW LEVELS EXCRETED WITH LOW RISK FOR ADVERSE EFFECTS IN INFANT
An adult over 60:
management or monitoring precaution: Neuro/Psych-Avoid in elderly with insomnia due to CNS stimulation effects.
management or monitoring precaution: General-Elderly have a higher incidence of systemic toxicities. Dose reduction may be needed.
management or monitoring precaution: Hepatic-Elderly are more susceptible to hepatotoxicity. Strict adherence to a maximum daily dose of 3000mg is advised.
Giving Back Pain-Off to a child under 12:
management or monitoring precaution: Use weight based dosing in children less than 12 years.
management or monitoring precaution: Adverse CNS effects of insomnia, restlessness, nervousness, and mild delirium, more severe in children.
Severe Precaution: Do not use in viral illness (influenza, varicella) due to possible increased risk of Reye syndrome. Consult clinician prior to use.
management or monitoring precaution: Caution in: seizure disorder, cardiovascular disease, or in premature neonates with renal or hepatic impairment.